These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 15654120)

  • 1. Thematic review series: The immune system and atherogenesis. Paying the price for pathogen protection: toll receptors in atherogenesis.
    Tobias P; Curtiss LK
    J Lipid Res; 2005 Mar; 46(3):404-11. PubMed ID: 15654120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional role for toll-like receptors in atherosclerosis and arterial remodeling.
    Vink A; de Kleijn DP; Pasterkamp G
    Curr Opin Lipidol; 2004 Oct; 15(5):515-21. PubMed ID: 15361786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-like receptor 4 and atherogenesis.
    Kiechl S; Wiedermann CJ; Willeit J
    Ann Med; 2003; 35(3):164-71. PubMed ID: 12822738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TLR signaling: an emerging bridge from innate immunity to atherogenesis.
    Michelsen KS; Doherty TM; Shah PK; Arditi M
    J Immunol; 2004 Nov; 173(10):5901-7. PubMed ID: 15528321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Toll-like receptor 4 in the initiation and progression of atherosclerotic disease.
    Pasterkamp G; Van Keulen JK; De Kleijn DP
    Eur J Clin Invest; 2004 May; 34(5):328-34. PubMed ID: 15147329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E.
    Michelsen KS; Wong MH; Shah PK; Zhang W; Yano J; Doherty TM; Akira S; Rajavashisth TB; Arditi M
    Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10679-84. PubMed ID: 15249654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antiinfective host defense mechanism: toll-like receptors and innate immunity].
    Takesue Y; Ohge H; Kohyama M; Imamura Y; Murakami Y; Sueda T
    Nihon Geka Gakkai Zasshi; 2003 Jul; 104(7):494-8. PubMed ID: 12884772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like receptors and the genetics of innate immunity.
    Cook DN; Hollingsworth JW; Schwartz DA
    Curr Opin Allergy Clin Immunol; 2003 Dec; 3(6):523-9. PubMed ID: 14612679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-like receptors, endogenous ligands, and systemic autoimmune disease.
    Rifkin IR; Leadbetter EA; Busconi L; Viglianti G; Marshak-Rothstein A
    Immunol Rev; 2005 Apr; 204():27-42. PubMed ID: 15790348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like receptors, their ligands, and atherosclerosis.
    Hodgkinson CP; Ye S
    ScientificWorldJournal; 2011 Feb; 11():437-53. PubMed ID: 21336459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atherosclerosis and innate immune signaling.
    Laberge MA; Moore KJ; Freeman MW
    Ann Med; 2005; 37(2):130-40. PubMed ID: 16026120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptors: linking innate and adaptive immunity.
    Pasare C; Medzhitov R
    Microbes Infect; 2004 Dec; 6(15):1382-7. PubMed ID: 15596124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of innate immune responses by Toll-like receptors.
    Takeda K; Akira S
    Jpn J Infect Dis; 2001 Dec; 54(6):209-19. PubMed ID: 11862002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like receptors and acquired immunity.
    Pasare C; Medzhitov R
    Semin Immunol; 2004 Feb; 16(1):23-6. PubMed ID: 14751760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-like receptors: critical proteins linking innate and acquired immunity.
    Akira S; Takeda K; Kaisho T
    Nat Immunol; 2001 Aug; 2(8):675-80. PubMed ID: 11477402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The toll of Toll-like receptors, especially toll-like receptor 2, on murine atherosclerosis.
    Curtiss LK; Tobias PS
    Curr Drug Targets; 2007 Dec; 8(12):1230-8. PubMed ID: 18220700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptors and their signaling mechanisms.
    Akira S; Sato S
    Scand J Infect Dis; 2003; 35(9):555-62. PubMed ID: 14620134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand-regulated chimeric receptor approach reveals distinctive subcellular localization and signaling properties of the Toll-like receptors.
    Nishiya T; DeFranco AL
    J Biol Chem; 2004 Apr; 279(18):19008-17. PubMed ID: 14976215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of oral pathogens with toll-like receptors: possible role in atherosclerosis.
    Hajishengallis G; Sharma A; Russell MW; Genco RJ
    Ann Periodontol; 2002 Dec; 7(1):72-8. PubMed ID: 16013219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution and integration of innate immune recognition systems: the Toll-like receptors.
    Takeda K
    J Endotoxin Res; 2005; 11(1):51-5. PubMed ID: 15826379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.